ATMOS, a Proof-of-Concept trial of inhaled mosliciguat in untreated PAH or CTEPHHossein Ardeschir Ghofrani, Grzegorz Kopeć, Pavel Jansa et al.|Unknown|2024Cited by 2
ATMOS, A Proof-of-Concept Trial of Inhaled Mosliciguat, A First-in-Class Soluble Guanylate Cyclase Activator – A Novel Approach to Address Unmet Needs in PHHossein Ardeschir Ghofrani, Grzegorz Kopeć, HH Leuchte et al.|American Journal of Respiratory and Critical Care Medicine|2025Cited by 1